Both oral and injectable GLP-1 therapies can cause nausea, constipation, or diarrhea, particularly during dose escalation
( The pathophysiology and prognosis of MMNST require further data for a comprehensive understanding, as well as to improve survival rates
Fillers can help restore volume in areas such as the cheeks, temples, under-eyes, and jawline after rapid weight loss
Among the surveyed participants, 43.5% were current smokers, while 17.4% reported becoming ex-smokers after initiating GLP-1 therapy
300 230EGP Description: A high-performance Korean sheet mask designed to brighten dull skin and even out the complexion
There are other forms of bias in these datasets including channeling (e.g., the prescribing pattern depends on a patient characteristic (particularly diabetes or obesity) that is a PDAC risk factor), detection (e.g., overreporting due to additional testing to rule out a suspected adverse event (e.g., imaging triggered by pancreas enzyme elevations)), and Weber effect (initial increase in event reporting shortly after drug launch) 49
.webp)
